Sam Altman-backed Retro Biosciences is raising $1 billion to develop drugs that extend human lifespan by 10 years, the FT ...

The Financial Times today cited sources as saying that OpenAI Chief Executive Sam Altman is participating in the investment.

The race to increase human life span through biotech just got tighter. Retro Biosciences, the AI-powered company whose ...

Retro Biosciences is raising a $1bn round to fund the artificial intelligence-powered biotech’s mission to increase human lifespan by a decade, starting by getting its first drug into trials this year ...

Disease-reversal startup Retro Biosciences is aiming for a $1 billion funding round, a spokesperson for the company confirmed ...

OpenAI CEO Sam Altman backs Retro Biosciences, a San Francisco-based biotech start-up that wants to extend human lifespan by ...

What's trending in Bay Area business news this Friday morning: Twilio, EA Sports, Headlands Brewing, GameOn, 345 California, Retro Biosciences and more.

Retro Biosciences, a startup that aims to use AI to aid in drug development, is reportedly raising $1 billion to support its research, with investors including OpenAI, which has previously backed ...

Sam Altman, the CEO of OpenAI, is backing a groundbreaking initiative aimed at extending human lifespan by a decade through ...